Genagon Therapeutics Competitors and Similar CompaniesClear all

Genagon Therapeutics's competitors and similar companies include Janssen, BioLineRx, Achilles Therapeutics and TSH Biopharm.
Genagon Therapeutics
Genagon Therapeutics
Genagon Therapeutics is a company that aims to increase response rates in immuno-oncology.
Janssen
Janssen
Janssen is a company providing prescription pharmaceutical products.
BioLineRx
BioLineRx
BioLineRx is a biopharmaceutical company focused on oncology.
Achilles Therapeutics
Achilles Therapeutics
Achilles Therapeutics is a developer of immunotherapies intended to offer therapies to treat cancer.
TSH Biopharm
TSH Biopharm
TSH Biopharm (東生華製藥股份有限公司) is a pharmaceutical company focused on chronic diseases.
Founding Date
Founding Date
2015
Founding Date
1953
Founding Date
2003
Founding Date
2016
Founding Date
2010
Type
Type
Private
Type
Subsidiary
Type
Public
Type
Private
Type
Public
Tags
Locations
Locations
Solna, SE HQ
Locations
Raritan, US HQ
Vienna, AT
Prague, CZ
Espoo, FI
Budapest, HU
Oslo, NO
Belgrade, RS
see more
Locations
Modi'in-Maccabim-Re'ut, IL HQ
Locations
London, GB HQ
Stevenage, GB
Locations
TW HQ
Employees
Employees
730% decrease
Employees
17,3684% decrease
Employees
2414% decrease
Employees
695% decrease
Employees
76

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
$1.2m (FY, 2025)
Revenue (est.)
N/A
Revenue (est.)
NT$1.3b (FY, 2025)
Cost of goods
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
$230k (FY, 2025)
Cost of goods
N/A
Cost of goods
NT$629m (FY, 2025)
Gross profit
Gross profit
N/A
Gross profit
N/A
Gross profit
$950k (FY, 2025)
Gross profit
N/A
Gross profit
NT$709.7m (FY, 2025)
Net income
Net income
N/A
Net income
N/A
Net income
($2m) (FY, 2025)
Net income
($69.7m) (FY, 2023)
Net income
NT$187.8m (FY, 2025)

Funding

Latest funding round
Latest funding round
$ 233.3k (over 10 years ago)
Latest funding round
N/A
Latest funding round
N/A
Latest funding round
$ 121m (over 6 years ago)
Latest funding round
N/A
Total funding raised
Total funding raised
$ 233.3k
Total funding raised
N/A
Total funding raised
$ 100.9m
Total funding raised
$ 138.1m
Total funding raised
N/A
For sources of this data, please see the company profile

View Company Profiles

Janssen
HQ
Raritan, US

Janssen is a company providing prescription pharmaceutical products.

View company
BioLineRx
HQ
Modi'in-Maccabim-Re'ut, IL
Employees
24↓ 14% decrease

BioLineRx is a biopharmaceutical company focused on oncology.

View company
Achilles Therapeutics
HQ
London, GB
Employees
69↓ 5% decrease

Achilles Therapeutics is a developer of immunotherapies intended to offer therapies to treat cancer.

View company
TSH Biopharm
HQ
TW
Employees
76

TSH Biopharm (東生華製藥股份有限公司) is a pharmaceutical company focused on chronic diseases.

View company